Hemophilia B is a rare genetic disorder that affects the blood's ability to clot due to a deficiency in clotting factor IX. It is less common than hemophilia A, which is caused by a deficiency in clotting factor VIII.

Hemophilia B accounts for approximately 15-20% of all hemophilia cases worldwide 1.
In the United States, out of about 30,000 people with hemophilia, around 7,000 have hemophilia B 2.
Globally, it is estimated that more than 1.1 million males have hemophilia, with hemophilia B being less prevalent compared to hemophilia A 23.
These figures highlight the 
